This may have been due to a direct induction of IL-10 by apremilast, as had been observed, to elevate IL-10 production by endotoxin-stimulated PBMC, and in the skin of psoriasis patients who achieved a clinical response PASI-75 or greater [5, 9]. The gene discussed is IL10; the disease is psoriasis.